Forte Biosciences, Inc. (FBRX) Shares Outstanding (Weighted Average) (2016 - 2020)
Forte Biosciences (FBRX) has disclosed Shares Outstanding (Weighted Average) for 5 consecutive years, with $11.2 million as the latest value for Q3 2020.
- On a quarterly basis, Shares Outstanding (Weighted Average) fell 99.47% to $11.2 million in Q3 2020 year-over-year; TTM through Sep 2020 was $11.2 million, a 99.47% decrease, with the full-year FY2019 number at $2.1 million, down 89.49% from a year prior.
- Shares Outstanding (Weighted Average) was $11.2 million for Q3 2020 at Forte Biosciences, up from $3.7 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $2.1 billion in Q1 2020 to a low of $2.1 million in Q4 2019.
- A 5-year average of $342.8 million and a median of $16.3 million in 2017 define the central range for Shares Outstanding (Weighted Average).
- Peak YoY movement for Shares Outstanding (Weighted Average): skyrocketed 10482.41% in 2019, then plummeted 99.83% in 2020.
- Forte Biosciences' Shares Outstanding (Weighted Average) stood at $2.2 million in 2016, then soared by 563.99% to $14.6 million in 2017, then surged by 37.32% to $20.1 million in 2018, then crashed by 89.49% to $2.1 million in 2019, then surged by 431.67% to $11.2 million in 2020.
- Per Business Quant, the three most recent readings for FBRX's Shares Outstanding (Weighted Average) are $11.2 million (Q3 2020), $3.7 million (Q2 2020), and $2.1 billion (Q1 2020).